Navigation Links
Global Lung Cancer Vaccine Market & Pipeline Outlook 2022
Date:1/12/2017

LONDON, Jan. 12, 2017 /PRNewswire/ -- "Global Lung Cancer Vaccine Market & Pipeline Outlook 2022" report analyzes ongoing clinical and non-clinical trends in the global lung cancer vaccine market. Currently there are 3 lung cancer vaccines commercially available in the market. This report analyzes the ongoing clinical trial of 30 lung cancer vaccines in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the lung cancer vaccines. Currently there are 9 lung cancer vaccines in advance Phase-II clinical trials followed by 8 vaccines Phase-I/II trials.

Lung cancer is emerging as one of the most lethal malignancy having high morbidity and mortality rates across the world. High mortality rates, high unmet medical necessities and modest efficacy of presently available lung cancer therapeutics have encouraged the demand for better and efficient lung cancer vaccines. More funds are being diverted into research and development segment to come up with lung cancer vaccine having high safety and efficacy profiles. Pharmaceutical companies have recognized the marketing potential of these vaccines in generating significant revenues and providing efficient medical care to patients across the world. Lung cancer vaccine market is largely untapped and offers significant opportunities to pharmaceutical companies to occupy large market shares across the globe.

At present majority of the lung cancer vaccines are in experimental stage and are still stuck in clinical trials due to which large unmet medical demands are still to be fulfilled. Boehringer Ingelheim and CureVac are developing lung cancer vaccine called CV9202 for the treatment of lung cancer which is at higher phase of clinical trials. GlaxoSmithKline is developing MAGE-A3 lung cancer vaccine which is also under investigation for other malignancies. Cell Genesys pharmaceutical company is developing GVAX for lung cancer and many clinical end points have been achieved during investigation.

Early market introduction of these drugs will be the major factor responsible for the increased marketing potential. Over time, they are expected to generate significant revenues owing to their safety and efficacy levels but till then this gap will be filled by other therapeutics. Further, those lung cancer vaccines which will make late entry have to face competition with previously marketed lung cancer vaccines giving them severe competition. This shows that pharmaceutical companies have to introduce their products in market as soon as possible to occupy major market shares across the globe. Thus, impact of early entrant will be more in global market and help them to generate significant revenues for some time before entry of worthy competitors.

Many pharmaceutical companies have already introduces cancer vaccines in global market and lung cancer segment is expected to get its first contender in coming years. Addition of lung cancer vaccines in this segment will further increase the size of global cancer vaccine market. Several other products belonging to different cancer indication will be entering in the global market leading to further increase in the market size. Advent of lung cancer vaccines is expected to improve this situation by increasing present survival rates and improve quality of life. Introduction of lung cancer vaccines are expected to gain major market shares among other cancer vaccines due to large patient population as compared to other disease indication.

Download the full report: https://www.reportbuyer.com/product/4543371/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-lung-cancer-vaccine-market--pipeline-outlook-2022-300390505.html


'/>"/>
SOURCE ReportBuyer
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Endoscopy Devices Market is Expected to Reach $40,854 Million, Globally, by 2022 - Allied Market Research
2. Atrial Fibrillation Market Global Competitive Analysis and 2021 Forecasts
3. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market is set to Cross US$ 5 Billion by 2024 - Persistence Market Research
4. Global Multiplexed Diagnostics Market to Reach US$26.36 Billion by 2024: Bolstered Funding for Genomics to Bode Well for Growth, predicts TMR
5. Global Combination Antibody Therapy Market to Reach US$ 144,734.5 Million by 2024 - Persistence Market Research
6. Global Mosquito Repellent Market 2017-2021
7. Global Medical Fiber Optics Market to Reach US$ 1,544.7 Million by 2024 - Persistence Market Research
8. Global Dysphagia Management Market Revenues Expected to Reach US$ 4,101.3 Million by 2024 - Persistence Market Research
9. Wound Dressings Market by Type , Application , End User - Global Forecast to 2021
10. Global Spine Biologics Market Forecast 2016-2026
11. Global Esophageal Reflux Partnering 2010-2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/5/2018)... ANGELES (PRWEB) , ... October 05, 2018 , ... A ... eons old fossils that are believed to be from the earth’s first predator, the ... smaller animals. Sometimes prey proved to be literally more than they conodonts could chew. ...
(Date:10/5/2018)... Calif. (PRWEB) , ... October 05, 2018 , ... ... for the annual Owners Summit meeting. A record number of franchisees attended the ... network of managed IT services providers (MSPs). The Owners Summit features several keynote ...
(Date:10/3/2018)... ... , ... Friends of Sheba Medical Center, Tel HaShomer and gala ... Sunday evening, October 14th, which will celebrate 70 years of saving lives at Israel’s ... members of the Israel Defense Forces (IDF) and civilians wounded during the War of ...
Breaking Medicine Technology:
(Date:10/6/2018)... ... ... Jose Rodriguez- Feliz M.D is a board–certified plastic surgeon ... for their exclusivity, and luxurious lifestyle publication is privileged to present Dr. Jose ... Haute Living network. , Haute Beauty consists of a prominent collective of ...
(Date:10/5/2018)... ... October 05, 2018 , ... ... care, LASIK/PRK and cataract surgery to patients residing in middle Tennessee and surrounding ... Ophthalmologists in the United States, Dr. Stewart Shofner has performed over ...
(Date:10/5/2018)... SPRINGS, Texas (PRWEB) , ... October 05, 2018 ... ... the Cerner Health Conference (CHC) 2018, an annual conference on the latest innovations ... will host this year’s event Oct. 8-11 throughout downtown Kansas City, Missouri. , ...
(Date:10/5/2018)... Ill. (PRWEB) , ... October 05, 2018 , ... The ... part of the process to cross the finish line with the passage of the ... part of the FAA Reauthorization Act of 2018. The legislation provides legal protection for ...
(Date:10/5/2018)... ... October 05, 2018 , ... Yisrayl Hawkins, Pastor and ... this week that focuses on Prophecy written thousands of years ago, but written for ... be fulfilled along with the Vatican and other leaders that he says, is taking ...
Breaking Medicine News(10 mins):